Anti-complement C1s antibodies and uses thereof
US12240917B2 · kind B2 · utility
0Cited by
29References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 10, 2021 |
| Grant date | Mar 4, 2025 |
| Priority date | — |
| Expiry date | Dec 10, 2041 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides antibodies that bind complement C1s protein; and nucleic acid molecules that encode such antibodies. The present disclosure also provides compositions comprising such antibodies, and methods to produce and use such antibodies, nucleic acid molecules, and compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.